China Wonder Share Discussion Threads

[mister md] 09/9/2010 09:36

LOL and $$$ ;))

[parvez] 08/9/2010 15:58

:) lots to see

[mister md] 08/9/2010 15:33

move on please, nothing to see here LOL !!!

[mister md] 27/8/2010 09:42

a week on, and the trend is still up ;)

[monis] 20/8/2010 09:11

NAV of 25p does not take into account this latest contract or any future contracts which are hinted at in the rns imo dyor.

[monis] 20/8/2010 08:53

Totally agree, these are ludicrously undervalued imo dyor.

[gng geong to hit 100p in 2011] 20/8/2010 08:51

The recent contract win alone is worth significant eps growth so some way to go, methinks.

[monis] 20/8/2010 08:46

Level 2 2v1, difficult to buy in any decent size and market makers wanting higher than the offer price suggest we should be due another move up imminently imo dyor.

[monis] 19/8/2010 09:14

Yes looking very good here imo. dyor.

[mister md] 18/8/2010 15:16

another buy trade at over 15p...

[monis] 18/8/2010 12:35

Level 2 looking very strong today would not be surprised if we see another move up... imo dyor.

[monis] 17/8/2010 14:20

Interesting. Last buy was well over the offer price...

[monis] 16/8/2010 12:54

Looking at the two recent tick up's today, i wonder if there is a big buy just about to be reported?

[monis] 16/8/2010 08:46

China Economy Surpasses Japan, Capping Three-Decade Rise
By Bloomberg News - Aug 16, 2010 7:01 AM GMT+0100



China surpassed Japan as the world's second-largest economy last quarter, capping the nation's three- decade rise from Communist isolation to emerging superpower.

Japan's nominal gross domestic product for the second quarter totaled $1.288 trillion, less than China's $1.337 trillion, the Japanese Cabinet Office said today. Japan remained bigger in the first half of 2010, the government agency said.

China led the world out of last year's global recession with an economy that's more than 90-times bigger than when leader Deng Xiaoping ditched hard-line Communist policies in favor of free-market reforms in 1978. The country of 1.3 billion people will overtake the U.S., where annual GDP is about $14 trillion, as the world's largest economy by 2027, according to Goldman Sachs Group Inc. chief economist Jim O'Neill.

China's surpassing of Japan "is a marker of its increasingly dominant role in the global economy," said Eswar Prasad, a senior fellow at the Brookings Institution and former head of the China division at the International Monetary Fund. "The resilience of China's growth during the crisis enabled a number of other countries, particularly commodity-exporting economies, to ride on its coattails."

China overtook the U.S. last year as the biggest automotive market and Germany as the largest exporter. The nation is the world's No. 1 buyer of iron ore and copper and the second- biggest importer of crude oil, and has underpinned demand for exports by its Asian neighbors.

Tricky Comparison

While China's output was also larger in the fourth quarter of 2009, Japan's GDP rebounded to exceed China's in the first quarter, according to data compiled by Bloomberg News. According to IMF data using purchasing-power-parity calculations to adjust for exchange-rate differences, China overtook Japan in 2001.

Quarterly comparisons between China and Japan are "a little tricky because they do not take account of different seasonal patterns between the two countries," said David Cohen, head of Asian forecasting at Action Economics in Singapore.

Still, China is on course to overtake the U.S. as the world's largest economy around 2020, PricewaterhouseCoopers said in a January report.

With China's growth surging 10.3 percent in the second quarter from a year earlier and Japan expanding 2 percent, the "gap is going to widen" in future, said Shen Jianguang, a Hong Kong-based economist at Mizuho Securities Asia Ltd. "It is not likely that Japan will retake the No. 2 spot given the likely growth rates."

Biggest Companies

Four of the world's top 10 companies by market capitalization are from China, including PetroChina Co., Industrial & Commercial Bank of China Ltd., China Mobile Ltd. and China Construction Bank Corp.

Agricultural Bank of China Ltd. boosted the size of its initial public offering to $22.1 billion this month after selling more stock in Shanghai, making it the world's largest first-time share sale. The IPO made the nation home to four of the world's 10 biggest banks by market value, half a decade after the country's first major state-owned lender went public.

China may be the world's biggest IPO market in 2010 as companies are likely to raise 500 billion yuan ($74 billion) in Shanghai and Shenzhen, PricewaterhouseCoopers forecast last month.

Since introducing free-market policies, China has lifted 300 million citizens out of poverty, according to the United Nations, even as the country remains a developing nation. Its per capita gross national income ranked 127th in the world at $2,940 at the end of 2008, behind Angola at 120th and Azerbaijan at 114th and ahead of Tonga at 133rd, according to the World Bank.

Developing Nation

"China has a large population, a weak economic foundation, relatively few resources and a large poverty population, which remains our basic situation," Ma Jiantang, head of China's statistics bureau, said in January. "Therefore, while we take note of our expanding size of economy and enhancing economic strength, we should also have a sober understanding that China remains a developing nation."

China's future influence on the global economy will increase, said Shen at Mizuho. The country's "double-digit" expansion will contribute a third of global growth this year, the Organization for Economic Cooperation and Development said in March.

"Japan had a huge impact on the global commodities market and foreign direct investment flows in the 1980s" as China is doing now, he said. "The major difference is that China's population is 10-times bigger than Japan's, its economy is still growing at above 9 percent per year, and Chinese investors are just beginning to invest abroad. You can imagine that China's impact will be so much bigger."

[monis] 16/8/2010 07:52

You also have to take on board this new contract plus by the sound of things in the rns, possibly more new contracts to come. imo.

Agree, great value imo.

[empirestate] 16/8/2010 00:19

net NAV here is around 18p after netting intangibles and top line p/e of around 4 so decent value at the mo

[monis] 13/8/2010 09:18

Good news for the companies pharmaceutical machinery business.

------



China Pharmaceutical Stocks Rally on Growth Prospects (Update1)
May 28, 2010, 3:21 AM EDT
More From Businessweek



May 28 (Bloomberg) -- Chinese drugmakers rallied to a three-week high in Shanghai and Shenzhen trading on the prospect government spending and increased investment from overseas companies will boost earnings growth.

A measure tracking health-care stocks on the CSI 300 Index gained 1.9 percent to 5,738.26. The CSI 300 slid 0.3 percent. Today's advance extended the group's gain to 10 percent in 2010, the most among the 10 industries after rising 94 percent in 2009.

China's pharmaceuticals market growth will accelerate to 20 percent to 25 percent this year, spurred by rising government spending and increased investment from multinational drugmakers, according to Katherine Lu, director of China equities at Oppenheimer & Co. The market grew between 16 percent and 18 percent last year, she said.

"Investment is long overdue," Lu, who covers health-care companies for the New York brokerage, said in a phone interview. "China is expected to become the third-largest health-care market by next year according to the IMF, that's ahead of projections that this would happen by 2013. The long-term growth outlook for the health-care market is very substantial."

The Chinese government spends $125 billion to start a national health insurance system. China's pharmaceuticals market, including nutritional products and consumer drugs, will more than double to $110 billion by 2015 from $44 billion in 2008, Credit Suisse AG estimated in a November 2009 report.

"The Chinese government is committed to health-care reform," Lu said. "China's savings rate is very high because people need to save for health. One way to stimulate spending and free up savings is by spending on health-care benefits."

Merger Potential

In April, Charles River Laboratories International Inc. agreed to buy WuXi PharmaTech (Cayman) Inc. for about $1.6 billion to expand in China, where revenue from drug-testing services is growing as much as 30 percent a year.

The WuXi acquisition "shows China's health-care market is going to be a global growth center over the next few years," Lu said.

"We see more deals in the M&A space," she said, adding the 3SBio Inc., a Chinese biotechnology company, has "good takeout potential."

Jiangsu Hengrui Medicine Co. gained 2.5 percent to 46.70 yuan in Shanghai, while Tianjin Tasly Pharmaceutical Co. advanced 6.2 percent to 33.04 yuan.

[monis] 12/8/2010 09:01

According to final results NAV per share is 25.97p. imo dyor.

Plus this latest contract with others according to the rns possibly to come - China Wonder on a PE of just under 5 look vastly undervalued imo dyor.

[monis] 11/8/2010 13:30

Looks like the price has moved up again...

[monis] 11/8/2010 07:57

After the very good set of results now an excellent new contract and by the sound of the rns it looks like we could have further contracts in that field to come imo dyor.

Excellent news.

[simonparker5] 10/8/2010 12:51

Is this company realy on a PE of 5 and net assets of 27p a share?

[mister md] 10/8/2010 11:42

always thought this looked undervalued